Editas Medicine Stock Forecast - Naive Prediction
| EDIT Stock | USD 2.16 0.22 9.24% |
The Naive Prediction forecasted value of Editas Medicine on the next trading day is expected to be 2.35 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.88. Editas Stock Forecast is based on your current time horizon.
At this time the rsi of Editas Medicine's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.26) | EPS Estimate Current Year (1.96) | EPS Estimate Next Year (1.14) | Wall Street Target Price 5.125 | EPS Estimate Current Quarter (0.38) |
Using Editas Medicine hype-based prediction, you can estimate the value of Editas Medicine from the perspective of Editas Medicine response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Editas Medicine using Editas Medicine's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Editas using crowd psychology based on the activity and movement of Editas Medicine's stock price.
Editas Medicine Short Interest
An investor who is long Editas Medicine may also wish to track short interest. As short interest increases, investors should be becoming more worried about Editas Medicine and may potentially protect profits, hedge Editas Medicine with its derivative instruments, or be ready for some potential downside.
200 Day MA 2.45 | Short Percent 0.1162 | Short Ratio 6.44 | Shares Short Prior Month 11.2 M | 50 Day MA 2.3225 |
Editas Medicine Hype to Price Pattern
Investor biases related to Editas Medicine's public news can be used to forecast risks associated with an investment in Editas. The trend in average sentiment can be used to explain how an investor holding Editas can time the market purely based on public headlines and social activities around Editas Medicine. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Editas Medicine Implied Volatility | 2.22 |
Editas Medicine's implied volatility exposes the market's sentiment of Editas Medicine stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Editas Medicine's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Editas Medicine stock will not fluctuate a lot when Editas Medicine's options are near their expiration.
The Naive Prediction forecasted value of Editas Medicine on the next trading day is expected to be 2.35 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.88. Editas Medicine after-hype prediction price | USD 2.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Editas Medicine to cross-verify your projections. Prediction based on Rule 16 of the current Editas contract
Based on the Rule 16, the options market is currently suggesting that Editas Medicine will have an average daily up or down price movement of about 0.14% per day over the life of the 2026-03-20 option contract. With Editas Medicine trading at USD 2.16, that is roughly USD 0.002997 . If you think that the market is fully incorporating Editas Medicine's daily price movement you should consider acquiring Editas Medicine options at the current volatility level of 2.22%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Editas Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Editas Medicine's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Editas Medicine's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Editas Medicine stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Editas Medicine's open interest, investors have to compare it to Editas Medicine's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Editas Medicine is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Editas. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Editas Medicine Additional Predictive Modules
Most predictive techniques to examine Editas price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Editas using various technical indicators. When you analyze Editas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Editas Medicine's financial statements to predict how it will affect future prices.
Cash | First Reported 2013-12-31 | Previous Quarter 138.5 M | Current Value 165.6 M | Quarterly Volatility 96.1 M |
Editas Medicine Naive Prediction Price Forecast For the 26th of January
Given 90 days horizon, the Naive Prediction forecasted value of Editas Medicine on the next trading day is expected to be 2.35 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.88.Please note that although there have been many attempts to predict Editas Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Editas Medicine's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Editas Medicine Stock Forecast Pattern
| Backtest Editas Medicine | Editas Medicine Price Prediction | Buy or Sell Advice |
Editas Medicine Forecasted Value
In the context of forecasting Editas Medicine's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Editas Medicine's downside and upside margins for the forecasting period are 0.02 and 6.69, respectively. We have considered Editas Medicine's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Editas Medicine stock data series using in forecasting. Note that when a statistical model is used to represent Editas Medicine stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.5919 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.08 |
| MAPE | Mean absolute percentage error | 0.0339 |
| SAE | Sum of the absolute errors | 4.8811 |
Predictive Modules for Editas Medicine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Editas Medicine. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Editas Medicine After-Hype Price Prediction Density Analysis
As far as predicting the price of Editas Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Editas Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Editas Medicine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Editas Medicine Estimiated After-Hype Price Volatility
In the context of predicting Editas Medicine's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Editas Medicine's historical news coverage. Editas Medicine's after-hype downside and upside margins for the prediction period are 0.11 and 6.63, respectively. We have considered Editas Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Editas Medicine is very risky at this time. Analysis and calculation of next after-hype price of Editas Medicine is based on 3 months time horizon.
Editas Medicine Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Editas Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Editas Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Editas Medicine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.56 | 4.34 | 0.13 | 0.37 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.16 | 2.29 | 6.02 |
|
Editas Medicine Hype Timeline
Editas Medicine is currently traded for 2.16. The entity has historical hype elasticity of 0.13, and average elasticity to hype of competition of 0.37. Editas is forecasted to increase in value after the next headline, with the price projected to jump to 2.29 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 6.02%, whereas the daily expected return is currently at -0.56%. The volatility of related hype on Editas Medicine is about 660.58%, with the expected price after the next announcement by competition of 2.53. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Historical Fundamental Analysis of Editas Medicine to cross-verify your projections.Editas Medicine Related Hype Analysis
Having access to credible news sources related to Editas Medicine's direct competition is more important than ever and may enhance your ability to predict Editas Medicine's future price movements. Getting to know how Editas Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Editas Medicine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CABA | Cabaletta Bio | 2.00 | 7 per month | 4.89 | 0.05 | 10.58 | (8.79) | 62.77 | |
| ALLO | Allogene Therapeutics | 0.00 | 8 per month | 3.24 | 0.1 | 9.76 | (5.93) | 21.23 | |
| PRQR | ProQR Therapeutics BV | (0.10) | 4 per month | 0.00 | (0.17) | 5.83 | (8.02) | 25.48 | |
| CAPR | Capricor Therapeutics | 1.60 | 10 per month | 4.29 | 0.12 | 11.97 | (10.26) | 386.29 | |
| KYTX | Kyverna Therapeutics Common | (0.47) | 9 per month | 7.85 | 0.08 | 10.86 | (9.60) | 55.75 | |
| IMMP | Immutep Ltd ADR | 0.27 | 6 per month | 2.90 | 0.14 | 7.41 | (5.41) | 31.54 | |
| AVIR | Atea Pharmaceuticals | 1.60 | 6 per month | 2.89 | 0.11 | 4.64 | (3.27) | 16.12 | |
| VYGR | Voyager Therapeutics | (0.17) | 9 per month | 0.00 | (0.11) | 4.58 | (5.23) | 19.71 | |
| LYEL | Lyell Immunopharma | 0.24 | 9 per month | 4.09 | 0.10 | 12.12 | (7.92) | 31.14 | |
| VNDA | Vanda Pharmaceuticals | 1.60 | 13 per month | 4.85 | 0.12 | 11.39 | (6.34) | 39.51 |
Other Forecasting Options for Editas Medicine
For every potential investor in Editas, whether a beginner or expert, Editas Medicine's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Editas Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Editas. Basic forecasting techniques help filter out the noise by identifying Editas Medicine's price trends.Editas Medicine Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Editas Medicine stock to make a market-neutral strategy. Peer analysis of Editas Medicine could also be used in its relative valuation, which is a method of valuing Editas Medicine by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Editas Medicine Market Strength Events
Market strength indicators help investors to evaluate how Editas Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Editas Medicine shares will generate the highest return on investment. By undertsting and applying Editas Medicine stock market strength indicators, traders can identify Editas Medicine entry and exit signals to maximize returns.
Editas Medicine Risk Indicators
The analysis of Editas Medicine's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Editas Medicine's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting editas stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.38 | |||
| Standard Deviation | 4.63 | |||
| Variance | 21.42 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Editas Medicine
The number of cover stories for Editas Medicine depends on current market conditions and Editas Medicine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Editas Medicine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Editas Medicine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Editas Medicine Short Properties
Editas Medicine's future price predictability will typically decrease when Editas Medicine's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Editas Medicine often depends not only on the future outlook of the potential Editas Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Editas Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.3 M | |
| Cash And Short Term Investments | 269.9 M |
Additional Tools for Editas Stock Analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.